Last reviewed · How we verify

NCT03233997

CSD170302: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes

Completed NA Last updated 20 October 2017
What this trial tests

NA trial testing FT21018 in Smoking in 121 participants. Completed in 30 September 2017.

Timeline
18 July 2017
Primary endpoint
30 September 2017
30 September 2017

Quick facts

Lead sponsorRAI Services Company
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment121
Start date18 July 2017
Primary completion30 September 2017
Estimated completion30 September 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

RAI Services Company

Who can join

Adults 21 to 60, any sex, with Smoking. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the rate and amount of nicotine uptake with 10-minute ad libitum use of four different marketed electronic cigarettes. Furthermore, to measure overall product liking by subjects to assess potential willingness to seek out the Electronic Cigarette (EC) again in the future.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of FT21018

Trials testing the same drug.

Other recruiting trials for Smoking

Currently open trials in the same condition.

Other RAI Services Company trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03233997.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing